Biological variability at the patient level.

Fact is, there is too much fluctuation present when using eGFR and UACR as the core measurements for kidney disease progression. For these to be reliable metrics to ascertain kidney disease staging, the patient results would need to be consistent from week to week. Studies indicate that this is not the case.



Hyperfiltration plays a critical role in chronic kidney disease in diabetes as it puts stress on the filtration barrier and post-filtration mechanisms.

What does all this mean?

Doctors should continue to use current measurements to diagnose chronic kidney disease and add the KidneyIntelXTM test to predict adult patients with type 2 diabetes and with chronic kidney disease stages 1-3 who are at low, intermediate or high risk for rapid progressive decline in kidney function.